Rhythm Pharmaceuticals buy Oppenheimer Holdings Inc.
Start price
20.12.24
/
50%
€55.50
Target price
20.12.25
€73.01
Performance (%)
69.37%
End price
21.12.25
€94.00
Summary
This prediction ended on 21.12.25 with a price of €94.00. The BUY prediction by Oppenheimer_Holdings for Rhythm Pharmaceuticals saw massive gains of 69.37%. Oppenheimer_Holdings has a follow-up prediction for Rhythm Pharmaceuticals where he still thinks Rhythm Pharmaceuticals is a Buy. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Rhythm Pharmaceuticals | 4.895% | 4.895% | 41.509% |
| iShares Core DAX® | 3,59 % | 6,43 % | 15,38 % |
| iShares Nasdaq 100 | 5,81 % | 6,38 % | 41,46 % |
| iShares Nikkei 225® | 4,08 % | 9,31 % | 48,95 % |
| iShares S&P 500 | 4,14 % | 4,94 % | 31,59 % |
Comments by Oppenheimer_Holdings for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $76.00 price target on the stock.
Ratings data for RYTM provided by MarketBeat
In the thread Trading Rhythm Pharmaceuticals
Die von Oppenheimer_Holdings gewählte maximale Laufzeit wurde überschritten
Current prediction by Oppenheimer_Holdings for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€76.50
10.07.25
10.07.25
€93.68
10.07.26
10.07.26
-1.31%
17.04.26
17.04.26
